These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24753319)

  • 1. Kinetics of protein fibrillation controlled by fibril elongation.
    Kashchiev D
    Proteins; 2014 Sep; 82(9):2229-39. PubMed ID: 24753319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
    Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
    Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein fibrillation due to elongation and fragmentation of initially appeared fibrils: a simple kinetic model.
    Kashchiev D
    J Chem Phys; 2013 Sep; 139(10):105103. PubMed ID: 24050370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
    Abelein A; Gräslund A; Danielsson J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian amyloidogenic proteins promote prion nucleation in yeast.
    Chandramowlishwaran P; Sun M; Casey KL; Romanyuk AV; Grizel AV; Sopova JV; Rubel AA; Nussbaum-Krammer C; Vorberg IM; Chernoff YO
    J Biol Chem; 2018 Mar; 293(9):3436-3450. PubMed ID: 29330303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid fibrillation kinetics: insight from atomistic nucleation theory.
    Cabriolu R; Auer S
    J Mol Biol; 2011 Aug; 411(1):275-85. PubMed ID: 21645521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    Biochemistry; 2014 Oct; 53(40):6302-8. PubMed ID: 25198136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of amyloid-β fibril elongation.
    Gurry T; Stultz CM
    Biochemistry; 2014 Nov; 53(44):6981-91. PubMed ID: 25330398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discrete mathematical model for the aggregation of β-Amyloid.
    Dayeh MA; Livadiotis G; Elaydi S
    PLoS One; 2018; 13(5):e0196402. PubMed ID: 29791461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions.
    Sabaté R; Villar-Piqué A; Espargaró A; Ventura S
    Biomacromolecules; 2012 Feb; 13(2):474-83. PubMed ID: 22176525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering and Fibril Formation during GNNQQNY Aggregation: A Molecular Dynamics Study.
    Szała-Mendyk B; Molski A
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32987720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
    Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
    Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel yeast cell-based system for studying the aggregation of Alzheimer's disease-associated Abeta peptides in vivo.
    von der Haar T; Jossé L; Wright P; Zenthon J; Tuite MF
    Neurodegener Dis; 2007; 4(2-3):136-47. PubMed ID: 17596708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of divalent copper, manganese and zinc ions on fibril nucleation and elongation of the amyloid-like yeast prion determinant Sup35p-NM.
    Suhre MH; Hess S; Golser AV; Scheibel T
    J Inorg Biochem; 2009 Dec; 103(12):1711-20. PubMed ID: 19853305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescent mutant of the NM domain of the yeast prion Sup35 provides insight into fibril formation and stability.
    Palhano FL; Rocha CB; Bernardino A; Weissmuller G; Masuda CA; Montero-Lomelí M; Gomes AM; Chien P; Fernandes PM; Foguel D
    Biochemistry; 2009 Jul; 48(29):6811-23. PubMed ID: 19530740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hydrophobic low-complexity region regulates aggregation of the yeast pyruvate kinase Cdc19 into amyloid-like aggregates
    Grignaschi E; Cereghetti G; Grigolato F; Kopp MRG; Caimi S; Faltova L; Saad S; Peter M; Arosio P
    J Biol Chem; 2018 Jul; 293(29):11424-11432. PubMed ID: 29853641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autocatalytic reaction as a model for the kinetics of the aggregation of beta-amyloid.
    Sabaté R; Gallardo M; Estelrich J
    Biopolymers; 2003; 71(2):190-5. PubMed ID: 12767118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide.
    Meisl G; Yang X; Frohm B; Knowles TP; Linse S
    Sci Rep; 2016 Jan; 6():18728. PubMed ID: 26758487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.